DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF
DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF
ETF · US26922A1491 · IBBJ (XNAS)
Overview
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - - - -
Asset Allocation
AssetPercentage %
Stock US90,52 %
Stock non-US9,18 %
Cash0,30 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
NTLAIntellia Therapeutics Inc 3,25 %
FATEFate Therapeutics Inc 2,66 %
ZLABZai Lab Limited 2,64 %
BBIOBridgeBio Pharma Inc 2,33 %
MEDPMedpace Holdings Inc 2,10 %
BEAMBeam Therapeutics Inc 2,02 %
VIRVir Biotechnology Inc 1,94 %
HALOHalozyme Therapeutics Inc 1,81 %
PACBPacific Biosciences of California Inc 1,69 %
APLSApellis Pharmaceuticals Inc 1,61 %
Region Distribution
RegionPercentage %
North America92,09 %
Asia Emerging3,25 %
Europe Developed2,95 %
Asia Developed0,78 %
United Kingdom0,50 %
Africa/Middle East0,43 %
Australasia0,00 %
Europe Emerging0,00 %
Japan0,00 %
Latin America0,00 %
Sector Distribution
SectorPercentage %
Gesundheitswesen100,00 %
Grundstoffe0,00 %
Verbrauchsgüter0,00 %
Finanzdienstleistungen0,00 %
Immobilien0,00 %
Telekommunikation0,00 %
Energie0,00 %
Industrieunternehmen0,00 %
Technologie0,00 %
Basiskonsumgüter0,00 %

Company Profile for DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF ETF

The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.
Fund Master Data
Issuer Defiance
Asset Class ETF
Name Defiance Nasdaq Junior Biotechnology ETF
Fund Currency USD
Category Health
fund.
Fund Key Figures
Fund Size 8.242,21 EUR
Investment Strategy
The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization (junior) companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a replication strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.

Company Data

Name DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF
Company Defiance Nasdaq Junior Biotechnology ETF
Symbol IBBJ
Primary Exchange XNAS NASDAQ
ISIN US26922A1491
Asset Class ETF
Sector Financial Services
Industry Asset Management
Country United States of America
Currency USD
Employees -
IPO Date 2020-08-03

Ticker Symbols

Name Symbol
NASDAQ IBBJ

More Shares

Investors who DEFIANCE NASDAQ JUNIOR BIOTECHNOLOGIESLOGY ETF hold also have the following shares in their portfolio:
BrandywineGLOBAL - U.S. Fixed Income ETF
BrandywineGLOBAL - U.S. Fixed Income ETF ETF
Q+M DENTAL GROUP SING.LTD
Q+M DENTAL GROUP SING.LTD Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025